Functional capacity in adults with cerebral palsy: Lower limb muscle strength matters by Gillett, Jarred G. et al.
Accepted Manuscript
Functional capacity in adults with cerebral palsy: Lower limb muscle strength matters.
Jarred G. Gillett, BExSc (Hons), Glen A. Lichtwark, Ph.D., Roslyn N. Boyd, Ph.D., Lee
A. Barber, Ph.D.
PII: S0003-9993(18)30094-7
DOI: 10.1016/j.apmr.2018.01.020
Reference: YAPMR 57155
To appear in: ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION
Received Date: 8 September 2017
Revised Date: 3 January 2018
Accepted Date: 17 January 2018
Please cite this article as: Gillett JG, Lichtwark GA, Boyd RN, Barber LA, Functional capacity in adults
with cerebral palsy: Lower limb muscle strength matters., ARCHIVES OF PHYSICAL MEDICINE AND
REHABILITATION (2018), doi: 10.1016/j.apmr.2018.01.020.
This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to
our customers we are providing this early version of the manuscript. The manuscript will undergo
copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please
note that during the production process errors may be discovered which could affect the content, and all
legal disclaimers that apply to the journal pertain.
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
Running Head: Functional capacity in cerebral palsy. 1 
Title: Functional capacity in adults with cerebral palsy: Lower limb muscle strength matters. 2 
Jarred G. Gillett, BExSc (Hons),1 Glen A. Lichtwark, Ph.D.,2, Roslyn N. Boyd, Ph.D.,1 and 3 
Lee A. Barber, Ph.D.,1 4 
Study performed at the Centre for Sensorimotor Performance, School of Human Movement 5 
and Nutrition Sciences, The University of Queensland, St Lucia, Australia. 6 
1
 Queensland Cerebral Palsy and Rehabilitation Research Centre, UQ Child Health Research 7 
Centre, Faculty of Medicine and Biomedical Sciences, The University of Queensland, South 8 
Brisbane, Queensland, Australia. 9 
2
 Centre for Sensorimotor Performance, School of Human Movement and Nutrition Sciences, 10 
The University of Queensland, St Lucia, Australia. 11 
Financial Support: This work was supported by Cerebral Palsy International [grant number 12 
R-810-13]; National Health and Medical Research Council of Australia [grant numbers 13 
1075642, 1070623, 1105038]; Cerebral Palsy Alliance [grant number CDG213]; and 14 
Australian Rotary Health and Rotary Club of St Ives. 15 
Acknowledgements: Professor Robert Ware for statistical advice, and Miss Shari O’Brien 16 
and Mr Ben van Dorsselaer for technical assistance with data collection. 17 
Disclosure of interests: None to declare. 18 
Corresponding author 19 
Jarred Gillett, BExSc (Hons I) 20 
Queensland Cerebral Palsy and Rehabilitation Research Centre  21 
Level 6, Centre for Children’s Health Research (LCCH), The University of Queensland 22 
62 Graham Street, South Brisbane, Queensland, Australia, 4101. 23 
Phone: +61 447 315 735 24 
Email: j.gillett1@uq.edu.au 25 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
1 
 
Title: Functional capacity in adults with cerebral palsy: Lower limb muscle strength matters. 1 
 2 
 3 
Abstract 4 
 5 
 6 
Objective: To investigate the relationship between lower limb muscle strength, passive 7 
muscle properties and functional capacity outcomes in adults with cerebral palsy (CP).   8 
 9 
Design: Cross-sectional study.  10 
 11 
Setting: Tertiary institution biomechanics laboratory.  12 
 13 
Participants: Sample of 33 adults with spastic-type CP with a mean age of 25 (range, 15-51) 14 
years; mean ± SD body mass 70.15 ± 21.35 kg; Gross Motor Function Classification System 15 
(GMFCS) level I n=20, level II n=13.  16 
 17 
Interventions: Not applicable.  18 
 19 
Main Outcome Measures: Six-minute walk test (6MWT) distance (m); lateral step-up 20 
(LSU) test performance (total repetitions); timed up-stairs (TUS) performance (s); maximum 21 
voluntary isometric strength of plantar flexors (PF) and dorsiflexors (DF) (Nm.kg-1); and 22 
passive ankle joint and muscle stiffness.  23 
 24 
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Results: Maximum isometric PF strength independently explained 61% of variance in 25 
6MWT performance; 57% of variance in LSU test performance; and 50% of variance in TUS 26 
test performance. GMFCS level was significantly and independently related to all three 27 
functional capacity outcomes, and age was retained as a significant independent predictor of 28 
LSU, and TUS test performance. Passive medial gastrocnemius muscle fascicle stiffness and 29 
ankle joint stiffness were not significantly related to functional capacity measures in any of 30 
the multiple regression models.  31 
 32 
Conclusions: Low isometric PF strength was the most important independent variable related 33 
to distance walked on the 6MWT, fewer repetitions on the LSU test, and slower TUS test 34 
performance. These findings suggest lower isometric muscle strength contributes to the 35 
decline in functional capacity in adults with CP.  36 
 37 
 38 
Keywords: Cerebral Palsy, muscle strength, walk test, muscle weakness, aging. 39 
 40 
 41 
Abbreviations: CP – cerebral palsy; DF – dorsiflexor; F – female; GMFCS – Gross Motor 42 
Function Classification System; GMFM – Gross Motor Function Measure; LG – lateral 43 
gastrocnemius; LSU – lateral step-up test; M – male; MG – medial gastrocnemius; PF – 44 
plantar flexor; SOL – soleus; TA – tibialis anterior; TD – typically developed; TUS – timed 45 
up-stairs test; 6MWT – six-minute walk test.  46 
 47 
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Ambulant young adults with cerebral palsy (CP) experience a decline in physical activity, 48 
aerobic capacity and walking ability into adulthood that is accelerated compared to typically 49 
developing (TD) adults, with a substantial reduction in mobility occurring before 40 years of 50 
age.1-5 There is a paucity of knowledge about the individual factors that contribute to the 51 
decline in function in adults with CP, however musculoskeletal adaptations such as muscle 52 
weakness6,7 and stiffness1,8 likely interact with the natural effects of ageing in some manner 53 
to limit functional capacity. There is a lack of understanding about how musculoskeletal 54 
development progresses through adulthood in individuals with CP and whether any decline in 55 
physical mobility is related to deterioration of muscle.  56 
 57 
Recent evidence suggests that a reduction in muscle strength and alterations in muscle 58 
structure, rather than increased spasticity, are associated with impaired gait function and 59 
measures of gross mobility,1,9-11 with strength accounting for up to 69% of the variance in 60 
gross motor function on the Gross Motor Function Measure (GMFM-66) score.12 The 61 
moderate relationship (adjusted R2 = 21–35%) between isometric lower leg strength and 62 
mobility capacity in children with CP that is not seen in TD individuals reinforces the 63 
importance of muscular strength to function in individuals with CP.13 Improvements in ankle 64 
muscle strength in young children with CP using resistance exercise programmes has been 65 
associated with improvements in the GMFM-66 walking, running, and jumping dimension 66 
(r=0.84).14 Similarly in adults with CP, improvements in ankle dorsiflexor (DF) function and 67 
range of movement during gait has been shown following explosive resistance training.15 68 
Although the adult CP literature is scarce regarding the relationship between plantar flexor 69 
(PF) strength and function, taken together, these findings suggest that muscle strength may 70 
play a key role in effective mobility and functional capacity in adults with CP as they age.  71 
 72 
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The resistance to passive movement in the absence of muscle activation is defined as passive 73 
stiffness, which may be due to structural musculoskeletal alterations rather than reflex-74 
mediated mechanisms.16-18 Adults with CP have significantly increased passive ankle and PF 75 
muscle stiffness compared to TD adults.1 Furthermore, this increased passive stiffness of the 76 
ankle muscles, along with muscle weakness, has been related to impaired gait function in the 77 
adults with CP.1 While these biomechanical parameters have been associated at a univariate 78 
level to impaired toe-lift, reduced gait-velocity, and active range of movement in adults with 79 
CP,1 whether they are related to different measures of functional capacity and their relative 80 
influence on different functional tasks remains unknown. 81 
 82 
A number of functional capacity measures have been used to assess walking ability and 83 
performance of gross motor tasks in individuals with CP.13,19-21 The six-minute walk test 84 
(6MWT) has been used as a measure of walking capacity and endurance in individuals with 85 
CP,20-22 however, it is difficult to determine the impact of musculoskeletal adaptations on 86 
walking capacity assessed using the 6MWT without objectively quantifying strength and 87 
muscle properties. Other functional capacity assessments related to strength, coordination, 88 
power, and speed of movement are the lateral step-up (LSU) test and timed up-stairs (TUS) 89 
test.13,23 In children with CP, isometric strength of the leg muscles has explained 28% and 90 
35% of the variance in LSU and TUS test performance respectively.13 How these various 91 
tasks are impacted by a further reduction in muscle strength and increased passive stiffness 92 
with ageing in individuals with CP is unknown. 93 
 94 
The quantification of the relationships between muscle strength, passive stiffness and 95 
functional capacity outcomes using multiple regression analysis will increase our 96 
understanding of the muscular factors underpinning the functional decline in adults with CP. 97 
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The aim of this study was to investigate the relationships between lower limb muscle 98 
strength, passive stiffness, and functional capacity outcomes in adults with CP.  It is likely 99 
that functional decline in adults with CP is impacted by the interaction of multiple factors, 100 
rather than one isolated characteristic (i.e. strength). We hypothesised that lower isometric 101 
muscle strength, increased passive muscle and ankle joint stiffness, and older age would be 102 
associated with reduced functional capacity outcomes.  103 
 104 
 105 
Methods 106 
 107 
 108 
Thirty-three community dwelling adults with spastic-type CP (18 M, 15 F; mean age 25 109 
years, range 15-51 years; mean ± SD body mass 70.15 ± 21.35 kg) participated in the study. 110 
Participants were recruited across South East Queensland and Sydney, Australia from the 111 
Queensland Cerebral Palsy Register; Cerebral Palsy League Queensland; Brisbane 112 
Paralympic Football Program; Cerebral Palsy Alliance; and expression of interest advertising. 113 
An estimated effect size of 0.4, and an alpha level of 0.05 was used in an a-priori sample size 114 
calculation with a power of 0.80, determining that 36 subjects were required to include 4 115 
factors into each model. The Gross Motor Function Classification System (GMFCS)24 levels 116 
of participants were established during the pre-screening process in an interview, with the 117 
following classification: Level I, n=18; Level II, n=15. Although developed for children with 118 
CP, the GMFCS has been used previously to classify the gross motor ability of adults with 119 
CP.25 Thirteen participants had received lower limb orthopaedic surgeries in the past, with 15 120 
participants also having previously received intramuscular Botulinum toxin-A injections to 121 
the lower limbs. This study was provided ethical clearance from the Human Research Ethics 122 
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Committees at The University of Queensland (2014000066; 2014000229) and The Cerebral 123 
Palsy Alliance (2015-09-02). Written and verbal information was provided to all participants 124 
prior to the study commencing, and signed written consent (or assent if under 18 years) was 125 
obtained. All data were collected between August 2014 and April 2017. 126 
 127 
 128 
Functional capacity 129 
 130 
 131 
The 6MWT was used to assess walking capacity and endurance measured as the maximum 132 
distance participants could walk during a 6-minute period on a 30m, flat, non-slippery track.26 133 
The LSU test was used as a composite measure of functional strength, coordination, power, 134 
and speed of movement performed on the left and right legs. Participants were required to 135 
stand with one leg on a 21cm box placed laterally to them, and the other leg on the ground. 136 
One repetition was recorded if the participant raised their standing leg from the start position 137 
to within 5 degrees of full extension on the box, and participants were instructed to complete 138 
as many repetitions as possible in 30s. The combined total of left and right leg repetitions was 139 
used in the analysis. The TUS test was used to assess mobility capacity walking up-stairs as a 140 
surrogate measure of a power task that occurs regularly in daily life. Participants were 141 
assessed on the time taken to ascend a six-step set of stairs as quickly as possible (without 142 
running), using a handrail if required, with the fastest time recorded from three trials used for 143 
subsequent analysis. The LSU and TUS tests were recorded on a video camera and analysed 144 
offline using freely available PC-based video analysis software.a Functional capacity 145 
outcomes were chosen a priori, and statistical regression analyses were only conducted on 146 
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these three outcomes. No participants wore ankle-foot orthoses during the functional capacity 147 
assessments. 148 
 149 
 150 
Dynamometry and passive movement assessments  151 
 152 
 153 
Participants laid prone on an adjustable plinth with their foot secured to a footplate of an 154 
isokinetic dynamometer.b Detailed information regarding participant setup and 155 
instrumentation used in this study have been reported elsewhere.8,27,28 Briefly, passive 156 
maximum ankle dorsiflexion range of motion was set in the dynamometer using a manually 157 
applied torque threshold greater than 20 Nm. Passive ankle joint torque and angle were 158 
measured during three slow passive trials at 10 deg.s-1 while electromyography (EMG) and 159 
B-mode ultrasound data of medial gastrocnemius (MG) muscle fascicles were simultaneously 160 
collected (Supplementary file 1). In a small subset of participants (n=4) the ankle was rotated 161 
in a similar footplate and at a similar speed, however, this was undertaken using manual 162 
rotation whilst simultaneously measuring the torque generated using a torque transducer and 163 
footplate angle using an accelerometer. 164 
 165 
Muscle activity levels were recorded from MG, lateral gastrocnemius (LG), soleus (SOL), 166 
and tibialis anterior (TA) using a differential surface EMG system.c Ultrasound images of 167 
MG muscle fascicles were acquired at 80Hz using a PC-based ultrasound scanner and a linear 168 
transducer fixed to the skin using elastic wrap.d Changes in muscle fascicle length and 169 
pennation angle were measured offline using semi-automated tracking algorithm.29-31 170 
Participants performed two unilateral maximum voluntary isometric contractions (MVIC) of 171 
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the ankle PF and DF at five angles corresponding to 5%, 25%, 50%, 75%, and 95% of the 172 
range between maximum PF and maximum DF. The trial that produced maximum torque was 173 
used for subsequent analysis. The passive torque measured at the same joint angle was 174 
subtracted from the maximum torque recorded during each MVIC to calculate the active 175 
torque produced by each participant. All torque measurements were corrected for the torque 176 
generated by gravity acting on both the foot and the footplate, using the geometric fitting 177 
method described in detailed by Barber et al.8 178 
 179 
 180 
Passive properties 181 
 182 
 183 
Medial gastrocnemius fascicle slack length was defined as the measured fascicle length (mm) 184 
from the slow passive ankle rotation at an ankle joint PF torque of 1Nm. Fascicle stiffness 185 
was calculated by fitting an exponential function to the mean muscle fascicle versus joint 186 
torque curve for passive ankle rotations. The stiffness value (k) is the coefficient obtained 187 
from the resultant exponential fit. Ankle slack angle (degrees) and ankle joint stiffness was 188 
calculated using the same procedure, fitting an exponential equation to the mean ankle angle 189 
versus joint torque curve (Supplementary file 2).  190 
 191 
 192 
Statistical analysis  193 
 194 
 195 
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Descriptive statistics are presented as means (SD) for normally distributed continuous 196 
variables, median (range) for non-parametric continuous variables, and as frequency (%) for 197 
categorical variables. Differences in outcome measures between GMFCS levels were 198 
assessed using a Student’s T test, or the Mann-Whitney U test if the variable was non-199 
parametric. The LSU and TUS test data was log transformed prior to regression analyses to 200 
account for their skewed distribution. Independent variables included age, sex, GMFCS, PF 201 
and DF MVIC, CP subtype (unilateral or bilateral), MG muscle fascicle and ankle joint 202 
passive stiffness, MG muscle fascicle slack length and ankle joint slack angle. The three 203 
functional capacity outcome measures were used as dependent variables. Multivariate 204 
regression of each functional capacity outcome was performed in a two-step process. Firstly, 205 
univariate associations between each of the functional capacity measures and independent 206 
variables were established. All independent variables with a univariate linear regression 207 
significance level of P ≤ 0.20 were retained. Secondly, variables that were retained from the 208 
univariate analyses were entered into a series of multiple linear regression models on a 209 
stepwise basis in order of the strength of their association. Cook's distance value was used to 210 
diagnose and remove outliers. All regression models were assessed for multicollinearity, 211 
heteroscedasticity and normality of residuals. There were no missing data.  212 
 213 
 214 
Results 215 
 216 
 217 
The personal demographics and characteristics categorised by GMFCS level are presented in 218 
Table 1. Descriptive statistics of the independent and dependent variables categorised by 219 
GMFCS level are presented in Table 2. There were significant differences between GMFCS 220 
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levels across all three functional capacity measures, with GMFCS level II walking less on the 221 
6MWT, performing less repetitions on the LSU test, and taking longer to ascend six stairs 222 
compared to participants who were GMFCS level I. All participants were able to complete 223 
the assessment tasks and no participant reported musculoskeletal pain during assessments. 224 
 225 
 226 
Six-minute walk test  227 
 228 
 229 
At a univariate level, there were associations between normalised PF and DF MVIC, MG 230 
slack length, height, age, limb involvement, and 6MWT distance that were significant at 231 
p<0.20 (Table 3). The final multiple linear regression model retained normalised PF MVIC, 232 
and GMFCS level (Table 4), F(2, 28) = 50.53, p<0.001, adjusted R2 = 0.77. No other 233 
independent variables were significant (p≤0.05) in the multiple linear regression model. 234 
 235 
 236 
Lateral step-up test 237 
 238 
 239 
Univariate linear regression revealed that normalised PF and DF MVIC, MG fascicle 240 
stiffness, ankle joint slack angle and MG slack length, age, and limb involvement were 241 
associated (p<0.2) with LSU performance (log transformed) (Table 3). Normalised PF 242 
MVIC, GMFCS level, and age were retained in the final regression model (Table 4), F(3, 26) 243 
= 29.36, p<0.001, adjusted R2 = 0.76. No other independent variables were significant 244 
(p≤0.05) in the multiple linear regression model.  245 
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 246 
 247 
Timed up-stairs 248 
 249 
 250 
Univariate analysis showed normalised PF and DF MVIC, ankle joint and MG fascicle 251 
stiffness, ankle joint slack angle and MG fascicle slack length, age and limb involvement to 252 
be significantly associated (p≤0.2) with TUS test performance (log transformed) (Table 3). 253 
Normalised PF MVIC, GMFCS level, and age were retained in the final model (Table 4), 254 
F(3, 28) = 27.06, p<0.001, adjusted R2 = 0.72. No other independent variables were 255 
significant (p≤0.05) in the multiple linear regression model. 256 
 257 
 258 
Discussion 259 
 260 
 261 
The multiple linear regression models developed in this study provide insight into potential 262 
underlying factors associated with walking ability and functional capacity in adults with CP. 263 
The main finding of this study was that maximum isometric PF strength explained 50 – 61% 264 
of the variance in 6MWT, LSU test and TUS test performance of adults with CP. Maximum 265 
isometric PF strength explained more of the variance in walking capacity (6MWT, 61%) and 266 
LSU test performance (57%) compared to the TUS test (50%) indicating the relative 267 
importance of the calf muscles to walking ability in adults with CP. Maximum isometric PF 268 
strength of adults with CP in this study (0.81 ± 0.51 Nm.kg-1) was approximately 50% less 269 
than what has been found in TD young adults (1.50 ± 0.37 Nm.kg-1), and approximately 35% 270 
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less than TD adults aged over 70 years (1.19 ± 0.36 Nm.kg-1).32 The relative reduction in 271 
muscle strength compared to TD adults is consistent with the literature describing muscle 272 
weakness in individuals with CP compared to their TD counterparts.7,13,27,33 Although not 273 
determined in this study, a loss of muscle volume,34 altered muscle quality,35 and changes in 274 
activation properties36 may explain the relative muscle weakness compared to TD 275 
individuals. 276 
 277 
The overall mean distance walked for adults with CP in this study on the 6MWT was 465.10 278 
± 155.40 m, which is in agreement with previously reported 6MWT distances in adults with 279 
CP of similar functional classification.22,23 Typically developed older men and women aged 280 
between 55 and 70 years have been shown to walk greater distances on the 6MWT,37 which 281 
may indicate an accelerated decline in walking capacity in the relatively younger adults with 282 
CP in this study (mean age 25 years) compared to older TD adults. Of our independent 283 
variables, maximum isometric PF strength, and GMFCS level were retained in the final 284 
regression model explaining a combined 77% of the variance in 6MWT distance. The 285 
significant relationship between PF strength and 6MWT in this study when controlling for 286 
GMFCS level, supports the evidence indicating the importance of the calf muscles in 287 
generating the power needed for an effective push-off during gait.38 This finding explains 288 
slightly more variance in 6MWT performance than has been shown in children and 289 
adolescents with CP, where ankle PF and hip flexor strength explained approximately 50% of 290 
the variance in 6MWT distance.11  291 
 292 
Our findings contradict a recent study assessing predictors of 6MWT performance in adults 293 
with CP (mean age 39 ± 12 years), where no relationship was found between lower limb 294 
muscle strength and 6MWT performance.22 The robustness of this finding is limited, 295 
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however, due to muscle strength being measured using a subjective manual muscle testing 296 
method without objectively quantifying joint torque. Our model also incorporated GMFCS 297 
level as an independent variable that was significantly associated with 6MWT distance in the 298 
final model. This finding may be considered intuitive as adults with CP who have higher 299 
gross motor function walk significantly greater distances on the 6MWT.22 Age has been 300 
previously reported as a significant independent predictor of 6MWT distance in TD older 301 
adults.39 Age, however, was not a significant independent predictor of 6MWT in this study. 302 
This finding is in agreement with the limited 6MWT literature in adults with CP, where no 303 
effect of age was found in a sample with a greater mean age (mean, SD 39 ± 12 years).22 The 304 
exclusion of age from our final 6MWT regression model may have been due to the relatively 305 
young to middle-age distribution of the participants, along with the presence of more 306 
important predictor variables.  307 
 308 
Maximum isometric PF strength explained the most variance in LSU test performance 309 
(adjusted R2=57%) and TUS test (adjusted R2=50%). For the LSU and TUS tests, GMFCS 310 
and age were also significantly and independently associated with test outcomes. There was, 311 
however, less variance explained by PF strength for the TUS regression model than for the 312 
6MWT and LSU test. Explanations for this include the potential use of the handrail for 313 
balance ascending stairs, as well as the likelihood for different neuromuscular demands and 314 
contribution of PF strength required in the TUS test. There was more variance explained by 315 
maximum PF strength in our sample of older adults for the LSU and TUS tests than has been 316 
shown in children with CP (28 – 35%).11,13 There is potentially greater deterioration in other 317 
physiological variables with ageing in individuals with CP, such as reduced rate of force 318 
development,1 reduced muscle activation capacity36 and increased co-contraction,36 319 
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culminating in a greater influence of muscle strength on these functional capacity outcomes 320 
compared to younger individuals.  321 
 322 
Clinically, joint stiffness (contracture) and muscle weakness are considered detrimental to 323 
functional capacity in individuals with CP. Even though MG muscle fascicle stiffness was 324 
higher in the GMFCS II group compared to GMFCS level I group, there was no significant 325 
relationship between passive muscle stiffness and any of the functional capacity outcomes in 326 
the multiple regression analyses. While passive stiffness has been shown to be moderately 327 
correlated to reduced toe-lift during gait (r=-0.48),1 compensatory movement strategies 328 
(altered kinematics) may be used by the individual to maintain walking and overall functional 329 
capacity.  330 
 331 
The significant relationship between PF strength and functional capacity outcomes found in 332 
this study indicates the potential for interventions targeting muscle weakness that may lead to 333 
improved function. Muscle weakness in adults with CP highlighted in this study indicates the 334 
need for early intervention to prevent the rapid decline in muscle health (muscle volume, 335 
quality, and function) that may occur before 30 years of age in adults with CP. To date, 336 
however, there is a lack of evidence linking an increase in lower limb strength following 337 
strength training interventions to improved functional capacity in adults with CP.23,40 The 338 
paucity of studies that have implemented robust progressive resistance training programs in 339 
individuals with CP, as well as the lack of objective neuromuscular outcome measures 340 
following the interventions, makes it difficult to draw conclusions regarding the effectiveness 341 
of strength training in this population.41 Given the high multimorbidity rates in middle-aged 342 
adults with CP, even without improvements in functional capacity following muscle 343 
strengthening interventions, there may be benefits to overall health wellbeing by maintaining 344 
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muscle mass and strength across the lifespan.42 The design of robust exercise training 345 
interventions in skeletally mature individuals with CP,28 with objective neuromuscular and 346 
functional outcome measures, show the most potential to further our understanding of the link 347 
between neuromuscular adaptation and functional capacity in this population.  348 
 349 
 350 
Study Limitations  351 
 352 
 353 
It is not possible to establish a cause and effect relationship using a regression approach. The 354 
generalisability of the findings in this study are limited to the independent variables that were 355 
measured and included in the regression analyses in adults with CP classified as GMFCS 356 
level I or II. It is plausible that other potential predictors of neuromuscular performance, such 357 
as activation capacity, play a role in the diminished functional capacity in adults with CP that 358 
were not captured in this study. The LSU and TUS tests also contain elements of strength 359 
endurance, balance, coordination and power that were not measured in isolation in this study. 360 
Due to the plasticity of the human musculoskeletal system, alternative strategies and 361 
mechanisms might contribute to accomplishing functional capacity outcomes, overcoming 362 
any detriment in isolated torque generating capacity and increased passive stiffness. 363 
Musculoskeletal pain may impact functional capacity outcomes in some individuals with CP, 364 
and quantification of pain levels may be considered for inclusion in future studies. Nine 365 
participants had previous lower limb muscle-tendon surgery that may have influenced 366 
isometric strength and functional capacity outcomes not specifically accounted for in the 367 
regression analyses. Due to the time since surgery (5-40 years); age of participants; and 368 
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heterogeneity of surgical procedures, it was not possible to determine the impact of the prior 369 
surgical interventions on the outcome measures in this study. 370 
 371 
 372 
Conclusions  373 
 374 
 375 
The results from this study further our understanding of how the deterioration of muscle 376 
strength is independently associated with functional decline in adulthood for people with CP. 377 
We therefore suggest that the relationship between muscle deterioration and functional 378 
decline with ageing in CP is primarily driven by a loss of muscle strength that can be 379 
measured objectively. Appropriately designed interventions to enhance muscle strength, such 380 
as progressive resistance training, might slow the decline in functional capacity and improve 381 
overall muscle health in individuals with CP as they age. 382 
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Table 1. Participant demographics and characteristics categorised by GMFCS level.  
Characteristic  Overall (n=33) GMFCS I (n=18) GMFCS II (n=15) 
Age, years, (range) 25 (15 – 51) 24 (15 – 41) 27 (17 – 51)  
Sex: M/F 18/15 10/8 8/7 
Height, cm 166.67 (12.68) 170.85 (10.00) 164.15 (12.53) 
Weight, kg 70.15 (21.35) 72.85 (19.12) 69.41 (26.10) 
Maximum passive DF angle (degrees)  
(median, range) 
15.45 (-21.99 – 28.86) 18.58 (1.61 – 28.86) 14.75 (-21.99 – 25.90) 
Lower limb involvement, n (%)    
 Unilateral 20 (61) 13 (72) 7 (47) 
 Bilateral 13 (39) 5 (27) 8 (53) 
Previous lower limb surgery, n (%)    
 Muscle-tendon lengthening  9 (27) 3 (17) 6 (40) 
 Osteotomy  3 (9) 0 (0) 3 (20) 
Previous intramuscular botulinum toxin-A injection, n 
(%) 
15 (45) 8 (44) 7 (47) 
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Use of mobility aid during functional capacity 
assessments, n (%) 
5 (15) 0 (0) 5 (33) 
Data are mean (SD) unless otherwise stated. *Significantly different to GMFCS Level I at p<0.05. 
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Table 2. Descriptive statistics of outcome measures categorised by GMFCS level.  
Outcome Overall (n=33) GMFCS I (n=18) GMFCS II (n=15) 
6MWT distance (m)  465.10 (155.40) 564.78 (112.98) 345.48 (107.65) 
LSU repetitions (n), median (range)  27.0 (4.0 – 74) 51.0 (22.0 – 74.0) 18.0 (4.0 – 38.0) 
TUS (s), median (range) 3.77 (2.30 – 16.78) 3.20 (2.30 – 4.93) 7.57 (3.0 – 16.78) 
MVIC (Nm.kg-1)    
 PF 0.81 (0.51) 1.01 (0.52) 0.57 (0.40)* 
 DF 0.15 (0.09) 0.18 (0.08) 0.11 (0.09)* 
Ankle joint stiffness (k) 0.10 (0.03) 0.09 (0.03) 0.11 (0.03) 
MG fascicle stiffness (k)  0.75 (0.88) 0.55 (0.49) 1.00 (1.16) 
Ankle joint slack angle (PF, deg) 17.44 (13.02) 19.94 (12.73) 15.15 (13.42) 
MG fascicle slack length (mm) 44.15 (12.10) 47.28 (10.32) 40.38 (13.34) 
Data are mean (SD) unless otherwise stated. *Significantly different to GMFCS Level I at p<0.05; Significantly different to GMFCS Level I at 
p<0.001. 
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Table 3. Univariate analysis of relationships between independent and dependent variables. Significant correlations (r) at p<0.05 are indicated in 
bold.  
 Six-minute walk test distance (m) Lateral step-up test (total repetitions) Timed up-stairs test (s) 
Age (years) -0.41 -0.58 0.56 
Height (m) 0.41 0.27 -0.23 
Weight (kg) -0.01 -0.05 0.03 
PF MVIC (Nm.kg-1) 0.65 0.71 -0.73 
DF MVIC (Nm.kg-1) 0.39 0.45 -0.53 
Ankle stiffness (k)  -0.20 -0.27 0.37 
MG fascicle stiffness (k) -0.32 -0.39 0.40 
Ankle slack angle (deg)  -0.30 -0.46 0.46 
MG fascicle slack length (mm)  0.39 0.38 -0.49 
For the timed up-stairs test, a negative correlation indicates a faster time.  
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Table 4. Results of multiple regression models. Adjusted R2 values indicate the cumulative R2 value for the regression model as each 
independent variable was entered in a stepwise process.  
Dependent variable n 
Independent variables entered 
stepwise into final model 
Regression coefficient 
± SE p Value Adjusted R2  
Six-minute walk test 32 (1 outlier 
removed) 
PF MVIC (Nm.kg-1) 
GMFCS level 
164.34 ± 29.45 
-148.65 ± 29.75 
<0.001 
<0.001 
0.61 
0.77 
Lateral step-up test 
(Log transformed)  
30 (3 outliers 
removed) 
PF MVIC (Nm.kg-1) 
GMFCS level 
Age 
0.27 ± 0.08 
-0.23 ± 0.06 
-0.011 ± 0.004 
0.002 
0.001 
0.007 
0.57 
0.68 
0.76 
Timed up-stairs test 
(Log transformed) 
32 (1 outlier 
removed) 
PF MVIC (Nm.kg-1) 
GMFCS level 
Age 
-0.17 ± 0.05 
0.18 ± 0.05 
0.008 ± 0.003 
0.003 
0.001 
0.007 
0.50 
0.64 
0.72 
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Supplementary Files: Figure Legends  1 
Supplementary file Figure 1. Representative data of (A) ankle joint angle, (B) ankle joint 2 
torque, and (C) normalised EMG during a passive ankle rotation from PF to DF in the 3 
dynamometer. Black line, MG EMG; red line, LG EMG; blue line, SOL EMG; grey line, TA 4 
EMG.  5 
 6 
Supplementary file Figure 2. Representative data of (A) ankle joint torque versus ankle joint 7 
angle, and (B) ankle joint torque versus MG muscle fascicle length during a passive ankle 8 
rotation from PF to DF in the dynamometer. Red line, trial 1; blue line, trial 2; black dashed 9 
line, mean of all trials; grey dashed line, exponential fit of the mean curve. 10 
